Tag: #tirzepatide

Articles related to tirzepatide

health

FDA proposes excluding semaglutide, tirzepatide and liraglutide from 503B bulks list

FDA proposes removing semaglutide, tirzepatide and liraglutide from the 503B bulks list, potentially limiting outsourcing facilities' ability to compound GLP‑1 drugs.

#fda, #glp1, #compounding, #semaglutide, #tirzepatide